Note 5. Segment Reporting (Segments Statements of Operations) (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Product revenue	$ 3,078,485	$ 3,640,761	$ 6,208,568	$ 5,910,338
Revenues, net	3,078,485	3,640,761	6,208,568	5,910,338
Cost of goods sold	1,510,322	1,776,054	3,066,536	2,972,452
Marketing, general and administrative	1,280,427	1,488,915	2,493,390	2,894,501
Research and development	377,042	266,169	700,232	530,367
Total costs and expenses	3,167,791	3,531,138	6,260,158	6,397,320
Loss from operations	(89,306)	109,623	(51,590)	(486,982)
Other Nonoperating Income (Expense)	6,535	16,842	7,603	81,623
Interest Expense	0	0	0	(92,596)
Total other (expense) income	6,591	16,904	7,720	(10,882)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(83,000)	126,527
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest	(82,715)	126,527	(43,870)	(497,864)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations	(82,715)	126,527	(43,870)	(497,864)
Income (Loss) from Continuing Operations Attributable to Parent	(83,000)	126,527
Sonomed-Escalon [Member]
Segment Reporting Information [Line Items]
Product revenue	3,078,485	3,640,761	6,208,568	5,910,338
Revenues, net	3,078,485	3,640,761	6,208,568	5,910,338
Cost of goods sold	1,510,322	1,776,054	3,066,536	2,972,452
Marketing, general and administrative	1,261,675	1,340,229	2,331,607	2,682,963
Research and development	377,042	266,169	700,232	530,367
Total costs and expenses	3,149,039	3,382,000	6,098,375	6,185,782
Loss from operations	(71,000)	258,309	110,193	(275,444)
Other Nonoperating Income (Expense)	0	0	0	0
Interest Expense			0	0
Total other (expense) income	0	0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(71,000)	258,309
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			110,193	(275,444)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			110,193	(275,444)
Income (Loss) from Continuing Operations Attributable to Parent	(70,554)	258,309
Corporate [Member]
Segment Reporting Information [Line Items]
Product revenue	0	0	0	0
Revenues, net	0	0	0	0
Cost of goods sold	0	0	0	0
Marketing, general and administrative	18,752	148,686	161,783	211,538
Research and development	0	0	0	0
Total costs and expenses	18,752	148,686	161,783	211,538
Loss from operations	(18,752)	(148,686)	(161,783)	(211,538)
Other Nonoperating Income (Expense)	7,000	17,000	7,603	81,623
Interest Expense			0	(92,596)
Total other (expense) income	6,591	16,904	7,720	(10,882)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(12,000)	(132,000)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			(154,063)	(222,420)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			(154,063)	(222,420)
Income (Loss) from Continuing Operations Attributable to Parent	$ (12,161)	$ (131,782)